Overview
Amarpreet Ahluwalia is a Pulmonary Medicine provider practicing medicine in Middle River, Maryland.
Her clinical expertise encompasses Nontuberculous Mycobacterial Lung Disease.
She is actively involved in clinical research, co-authoring 6 peer reviewed articles.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
6201 Greenleigh Ave, Middle River, MD 21220
4940 Eastern Ave, Baltimore, MD 21224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Sonye Danoff, MD is a Pulmonologist in Baltimore, MD and has over 29 years of experience in the medical field. Dr. Danoff has extensive experience in Obstructive Lung Disease and Sleep Apnea. She graduated from Johns Hopkins School of Medicine in 1993. She is affiliated with medical facilities Johns Hopkins Bayview Medical Center and The Johns Hopkins Hospital. Dr. Danoff is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Endoscopy, and Lung Transplant. Dr. Danoff is board certified in American Board Of Internal Medicine (Pulmonary Disease) (1999).
Inova Medical Group - Transplant Specialties
Schar Chair, Advanced Lung Disease and Lung Transplant Medical Director, Advanced Lung Disease and Lung Transplant Program, Inova Schar Heart and Vascular Professor of Medical Education, University of Virginia, Inova CampusSteven D. Nathan, MD, FCCP, is the medical director of Inova’s Advanced Lung Disease Program and Lung Transplant Program. He is also a professor of medicine at the University of Virginia.Dr. Nathan is board certified in pulmonary diseases, critical care medicine and internal medicine. The author of more than 500 publications, Dr. Nathan is internationally recognized for his expertise in advanced lung diseases. He is co-editor of two books on idiopathic pulmonary fibrosis that provide pulmonologists and other healthcare workers with an up-to-date review of the background and advances in the field: Idiopathic Pulmonary Fibrosis and Guide to Clinical Management of Idiopathic Pulmonary Fibrosis. He also has written original research manuscripts, abstracts, reviews and book chapters. Dr. Nathan is a reviewer for multiple journals and is on the editorial board for the journal, Thorax. He has served on multiple committees, including U.S. Food and Drug Administration advisory boards as well as steering committees for clinical trials in IPF and pulmonary hypertension, where he has also served as chair. Dr. Nathan is a member of several professional medical associations, including the American Thoracic Society, the American College of Chest Physicians, and the International Society for Heart and Lung Transplantation. He has delivered talks and been chairperson of numerous sessions at many national and international conferences. Dr. Nathan is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Prostatectomy. Dr. Nathan is currently accepting new patients.
Johns Hopkins Bayview Medical Center
Dr. Lee is a specialist in Interventional Pulmonary and serves as the Wang Interventional Pulmonary Fellowship Director. His areas of clinical expertise include interventional pulmonology, pleural disease, minimal invasive diagnostics and lung cancer at Johns Hopkins. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management and difficulty airways. In addition, he specializes in the diagnosis and management of pleural diseases and symptom relief with minimally invasive procedures. He is a fellow of the American College of Chest Physicians and the Johns Hopkins Master of Education for Health Professionals. Dr. Lee is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Lung Nodules, Lung Adenocarcinoma, Endoscopy, and Trabeculectomy. Dr. Lee is board certified in American Board Of Internal Medicine. Dr. Lee is currently accepting new patients.
Frequently Asked Questions about Dr. Amarpreet K. Ahluwalia
How do I make an appointment with Dr. Amarpreet K. Ahluwalia?
You can book an appointment with Dr. Amarpreet K. Ahluwalia by calling their office at 410-550-3350. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Amarpreet K. Ahluwalia a top-rated expert for Nontuberculous Mycobacterial Lung Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Amarpreet K. Ahluwalia is classified as an Experienced expert for Nontuberculous Mycobacterial Lung Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Amarpreet K. Ahluwalia specialize in?
While Dr. Amarpreet K. Ahluwalia is a Pulmonary Medicine, they have specific expertise in Nontuberculous Mycobacterial Lung Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.
Does Dr. Amarpreet K. Ahluwalia participate in research or clinical trials?
Yes. Dr. Amarpreet K. Ahluwalia has published 6 articles and abstracts on conditions like Nontuberculous Mycobacterial Lung Disease. You can view a list of Dr. Amarpreet K. Ahluwalia's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Amarpreet K. Ahluwalia accept my insurance?
Dr. Amarpreet K. Ahluwalia accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-550-3350 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Nontuberculous Mycobacterial Lung DiseaseDr. Ahluwalia isExperienced. Learn about Nontuberculous Mycobacterial Lung Disease.


